コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 o were premenopausal at baseline and reached natural menopause.
2 my with the changes observed up to and after natural menopause.
3 icant independent predictor of the timing of natural menopause.
4 teristics were associated with the timing of natural menopause.
5 /ethnicity were associated with later age at natural menopause.
6 sed to assess factors associated with age at natural menopause.
7 reported increased mortality risk with early natural menopause.
8 e at menopause than women who have undergone natural menopause; 2) reliability declines with time sin
11 vestigated factors influencing the timing of natural menopause among 95,704 women with a mean age of
12 perfluorohexane sulfonate (PFHxS) and age at natural menopause among women 20-65 years of age in NHAN
13 used to examine the relation between age at natural menopause and all-cause and cause-specific morta
14 sk associated with MHT in women experiencing natural menopause and for late age at natural menopause
15 in those observational studies had undergone natural menopause and were treated for the relief of men
17 with age, duration of breastfeeding, age at natural menopause, and duration of estrogen use differed
18 vely with early age at menarche, late age at natural menopause, and total length of ovulation span, b
23 stimate hazard ratios (HRs) for the onset of natural menopause as a function of age and serum PFC lev
24 nts previously associated with normal age at natural menopause as a quantitative trait (QT) were also
25 53 (95% confidence interval: 0.58, 4.07) for natural menopause at age < or =45 years compared with >
26 sed women were 50% more likely to experience natural menopause at any given age (hazard ratio = 1.49,
28 erapy, who never smoked, and who experienced natural menopause between the ages of 40 and 54 years.
30 ars (subtracting age at menarche from age at natural menopause), from 36.1 years among women born bet
32 risk of BCC was associated with late age at natural menopause (hazard ratio [HR] for >/= 55 years v
34 ed survival analyses to estimate the risk of natural menopause in 4,210 DES-exposed versus 1,829 unex
35 ts support the hypothesis that the timing of natural menopause is driven by a combination of genetic,
37 ne withdrawal (such as following surgical or natural menopause) may impact the efficacy of progestero
38 ardiovascular disease (CVD) before and after natural menopause (NM), hysterectomy with at least 1 ova
39 seven traits related to reproductive (age at natural menopause, number of children, age at first chil
42 eline, postmenopausal includes patients with natural menopause or that induced by ovarian suppression
45 or women who experienced premature or early natural menopause should be considered for hormonal trea
46 ciation between early-life events and age at natural menopause, the authors used Cox proportional haz
47 ere fitted to examine the relation of age at natural menopause to lifestyle and anthropometric factor
48 ffect of women's lifestyles on the timing of natural menopause using data from a cross-sectional ques
51 demographic and lifestyle factors to age at natural menopause was examined in seven US centers and f
53 ed with rate of hysterectomy, and time since natural menopause was positively associated with serum P
55 rospective cohort study of 6040 women with a natural menopause were followed up at 3-y intervals over
56 re all independently associated with earlier natural menopause, while parity, prior use of oral contr
57 isk was most increased among women reporting natural menopause who used MHT for 10 or more years vers
58 d 50,678 women (21,511 who had experienced a natural menopause) who were 40-98 years of age at study
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。